Lv52
1380 积分 2024-09-01 加入
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
55分钟前
待确认
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
18小时前
待确认
Progress in the development of cytokine armoured CAR T cells
2天前
已完结
SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMM
4天前
已完结
Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation
5天前
已关闭
How I Treat HLH-Like Toxicities Following Immune Effector Cell Therapy
6天前
已关闭
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
8天前
已完结
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation
9天前
已完结
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
9天前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
13天前
已完结
皖公网安备34019202002308
